All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

NMN vs TRT for energy and testosterone: what the research says

Paul Schriner

TikTok creator

12.4K viewsWatch on TikTok→

Quick answer

NMN is a NAD+ precursor with emerging research in metabolic and cellular aging contexts, but no completed human RCTs have demonstrated that it raises serum testosterone to levels comparable to TRT in men with clinical hypogonadism. TRT remains the standard of care for confirmed low testosterone, with established dosing protocols and monitoring requirements that a $50/month sublingual supplement does not replicate. Patients experiencing fatigue, low libido, or other hypogonadism symptoms should pursue serum testosterone and LH testing before making treatment decisions based on supplement marketing.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @paulschriner actually say?

The short version: NMN supplements can replace TRT by restarting your "cellular factories," NAD decline after 30 is to blame for low testosterone, and the FDA is about to kill your access to cheap NMN. He claims his biohacking group saw "73% more energy in 30 days" and frames TRT as an industry scam while selling a $50/month sublingual supplement.

He's not subtle about the sales pitch. "Tap the cart and give them what they need" closes a video that opens with a genuine biochemistry question and ends as a product advertisement. That framing matters when we evaluate the science.

Does the science back this up?

Partially, and that's being generous. The Leydig cell-NAD connection is real biology. The leap from that biology to "NMN replaces TRT" is not supported by clinical evidence in humans.

Leydig cells in the testes do express NAD-dependent enzymes, including sirtuins, and animal research has shown that NAD precursor supplementation can influence steroidogenesis. A 2020 study by Yoshino et al. in Cell Metabolism found that NMN supplementation improved insulin sensitivity in postmenopausal women but did not measure testosterone. A 2023 randomized controlled trial by Yi et al. in GeroScience found modest NAD+ increases in older adults taking NMN, with no significant testosterone data reported. The gap between "NAD supports Leydig cell function in mice" and "NMN raises your testosterone like TRT" is enormous, and no peer-reviewed human trial has closed it.

The "NAD crashes harder than crypto after 30" line is directionally accurate. NAD+ levels do decline with age, as documented by Verdin in Science (2015). Whether that decline is the primary driver of age-related testosterone decline is unproven.

What did they get wrong (or right)?

Let's give credit where it's due. The basic science premise, that NAD+ is involved in Leydig cell function and declines with age, is not invented. That's real. The claim that TRT causes testicular atrophy is also accurate. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH signaling to the testes, which shrinks them. That's textbook endocrinology.

Here's what's wrong. The "73% more energy" figure comes from his biohacking group, not a controlled study. That is anecdote laundered as data. Self-reported energy in a group of people already biased toward believing in a supplement they're taking together is about as reliable as a Yelp review written by the owner's cousin.

The claim that NMN "works better than TRT" for energy is unverifiable and almost certainly false for men with clinically confirmed hypogonadism. TRT has decades of controlled trial data. NMN has promising preclinical work and early-phase human trials. Presenting them as interchangeable alternatives is misleading in a way that could actually harm people who need treatment.

The FDA warning is also distorted. The FDA has flagged NMN because a pharmaceutical company filed an Investigational New Drug application, which legally complicates its sale as a supplement. That's a regulatory technicality, not a pharmaceutical conspiracy.

What should you actually know?

If you have symptoms of low testosterone, including fatigue, low libido, or mood changes, get a blood test. A single TikTok video about Leydig cells is not a diagnostic tool. NMN may support cellular energy metabolism, and the research is genuinely interesting, but it has not been shown in human trials to raise testosterone to therapeutic levels in men with hypogonadism.

TRT is not a scam. It is an FDA-approved treatment with real efficacy data for men who are actually deficient. Its downsides, including testicular atrophy and the need for monitoring, are real too, which is why it requires clinical oversight. NMN is not a replacement for that process.

If you want to explore NAD precursor supplementation, that's a reasonable conversation to have with a clinician. But making that decision based on a sales video that closes with "tap the cart" is a bad way to manage your health. The supplement industry is not your friend just because it's cheaper than a clinic.

Should you be worried about this video?

Yes, moderately. The danger here isn't outright fiction. It's a half-true framework used to sell a product and discourage people from seeking legitimate evaluation. Men with actual hypogonadism who watch this and decide to buy sublingual NMN instead of getting labs done may delay diagnosis of treatable conditions. That's a real harm, even if the biochemistry in the first 20 seconds is technically defensible.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For NMN vs TRT for energy and testosterone: what the research says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

NMN vs TRT for energy and testosterone: what the research says should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

Compare available products and select the relevant treatment page for its specific next step.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

NMN is a NAD+ precursor with emerging research in metabolic and cellular aging contexts, but no completed human RCTs have demonstrated that it raises serum testosterone to levels comparable to TRT in men with clinical hypogonadism.

FormBlends verdict

NMN is a NAD+ precursor with emerging research in metabolic and cellular aging contexts, but no completed human RCTs have demonstrated that it raises serum testosterone to levels comparable to TRT in men with clinical hypogonadism. TRT remains the standard of care for confirmed low testosterone, with established dosing protocols and monitoring requirements that a $50/month sublingual supplement does not replicate. Patients experiencing fatigue, low libido, or other hypogonadism symptoms should pursue serum testosterone and LH testing before making treatment decisions based on supplement marketing.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • NMN is a NAD+ precursor with emerging research in metabolic and cellular aging contexts, but no completed human RCTs have demonstrated that it raises serum testosterone to levels comparable to TRT in men with clinical hypogonadism. TRT remains the standard of care for confirmed low testosterone, with established dosing protocols and monitoring requirements that a $50/month sublingual supplement does not replicate. Patients experiencing fatigue, low libido, or other hypogonadism symptoms should pursue serum testosterone and LH testing before making treatment decisions based on supplement marketing.
  • NAD+ declines with age are documented in humans (Verdin, Science, 2015), but no human RCT has shown NMN supplementation raises testosterone to therapeutic levels in hypogonadal men.
  • Testicular atrophy is a real and documented side effect of TRT due to LH suppression. The creator is correct on this point.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • NAD+ declines with age are documented in humans (Verdin, Science, 2015), but no human RCT has shown NMN supplementation raises testosterone to therapeutic levels in hypogonadal men.
  • Testicular atrophy is a real and documented side effect of TRT due to LH suppression. The creator is correct on this point.
  • The '73% more energy' figure comes from an uncontrolled, unblinded biohacking group. It is anecdote, not data.
  • A 2023 GeroScience RCT (Yi et al.) confirmed NMN raises NAD+ levels in older adults but did not report significant effects on testosterone or measure it as an endpoint.
  • Men with fatigue or low libido should get serum testosterone and LH tested before choosing between TRT and any supplement. Symptoms alone do not diagnose hypogonadism.
  • The FDA's NMN regulatory action stems from an Investigational New Drug application filed by a pharmaceutical company, not a campaign to protect TRT market share.
  • NMN and TRT work through completely different mechanisms and have not been tested head-to-head in any clinical trial. Framing them as equivalent alternatives is not supported by evidence.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Paul Schriner · TikTok creator

12.4K views on this video

Why NMN Works Better Than TRT for Energy - Natural Testosterone Not medical advice. Results vary. Your doctor might learn something from you. #NMNbenefits #NaturalTestosterone #TRTalternative #LeydigCells #mitochondriahealth

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Paul Schriner, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.